Moxicip KT Eye Drop is a preservative-free, sterile, and isotonic solution for ophthalmic use, containing Ketorolac 0.5% w/v and Moxifloxacin 0.5% w/v. This combination therapy is indicated for the treatment of conjunctivitis, including viral and bacterial conjunctivitis, and post-operative ocular inflammation. The topical administration of Ketorolac and Moxifloxacin in Moxicip KT Eye Drop provides a synergistic effect in reducing inflammation and treating infection. The Ketorolac component exhibits potent anti-inflammatory properties, while Moxifloxacin is a broad-spectrum antibiotic effective against a wide range of Gram-positive and Gram-negative bacteria, including Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. The solution is free of preservatives, making it suitable for use in patients with known sensitivity to preservatives. The recommended dosage is one to two drops in the affected eye(s) every 4 to 6 hours as needed. Moxicip KT Eye Drop should be used under the guidance of a healthcare professional and in accordance with the product's instructions for use.